Pricing
Not listed
Official monthly price not confirmed
- API
- Not confirmed
Promakhos Therapeutics
● Identity checkedBiotech · Vendor site 2026-10-04
Promakhos Therapeutics is a Boston-based biotech company developing medicines for autoinflammatory diseases by restoring immune balance instead of broadly suppressing immunity. The team uses insights from patient samples to target root causes of chronic inflammation.
- Category
- Biotech
- Free access
- Not confirmed
- API access
- Not confirmed
Is Promakhos Therapeutics right for you?
A good fit for
Patients, clinicians, and partners following novel autoinflammatory therapies—not a software buyer audience.
Before you choose
Corporate site describes R&D pipeline and team bios without commercial software or subscription offerings.
Autoinflammatory R&D
Promakhos describes a Boston startup founded in 2021 to create therapies that help the body control inflammation and heal.
What it can do
Features & capabilities
Unknown is different from unavailable. Each fact carries its own evidence.
| Capability | Value | Evidence | Checked |
|---|---|---|---|
| Therapeutic focus | Site states the company develops transformative medicines for inflammatory diseases such as Crohn’s and psoriasis. | Facts sourced | 2026-10-04 |
| Immune restoration | Marketing contrasts restoring immune function with traditional immunosuppressive therapies. | Facts sourced | 2026-10-04 |
Understand the total cost
Promakhos Therapeutics pricing & plans
Alternatives to Promakhos Therapeutics
View all ↗
ConsensusConsensus is an AI academic search engine over peer-reviewed literature. It supports paper search plus Pro and Deep modes that synthesize evidence, study snapshots, and collections, with optional API and MCP access on paid tiers for students, clinicians, and researchers.
Explore tool
Zendesk AIZendesk AI powers the company's Resolution Platform with AI agents, Copilot, intelligent automation, and knowledge tools that learn from service interactions. It is sold as part of Zendesk customer service plans rather than a standalone chatbot app.
Explore tool
AI PDF bank statement parserAI Bank Parser converts PDF bank statements into CSV, Excel, QBO, and JSON using AI table extraction. The web app and REST API target accountants, developers, and finance teams automating statement imports.
Explore toolThe practical questions
Frequently asked questions
What is Promakhos Therapeutics used for?
Promakhos Therapeutics is a Boston-based biotech company developing medicines for autoinflammatory diseases by restoring immune balance instead of broadly suppressing immunity. The team uses insights from patient samples to target root causes of chronic inflammation.
Does Promakhos Therapeutics have a free plan?
Not confirmed. This record does not confirm an ongoing free plan.
How much does Promakhos Therapeutics cost?
A listed monthly price has not been confirmed. See the plan cards for entitlements, billing commitments and seat minimums.
Can I use Promakhos Therapeutics through an API?
Not confirmed. API access and subscription access may have different terms; consult the linked sources.
What should I check before choosing it?
Corporate site describes R&D pipeline and team bios without commercial software or subscription offerings.
Price history
No retained pricing changes yet. A current price alone does not establish a historical trend.
How this profile is supported
Identity and profile
Reviewed vendor source
Read original source ↗Facts apply to the named version and check date. Send a sourced correction if something changed.